Big setback for Merck cholesterol drug
32044
High doses of Zocor provide no benefits in preventing new problems in heart attack patients: study. MUNICH  - Merck&#39;s anti-cholesterol drug Zocor suffered a setback after a major study found high
319815
Pharmaceutical giant Merck &amp; Co. abruptly ordered a worldwide recall of its premier arthritis drug Vioxx on Thursday after a company-run study confirmed that long-term use of the pills increased risk of heart attack and stroke.
20275
Shares of Merck &amp; Co. plunged more than 7 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.
247288
Merck &amp; Co. withdrew its Vioxx painkiller, which generated $2.5 billion in sales last year, because of a link to heart attacks and strokes.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
90293
The company that makes the drug, Merck, said the company recalled the drug voluntarily after it received new research results. The results showed people taking the drug for several years have an increased risk of heart attack and stroke.
280913
SILVER SPRING, Maryland  - A U.S. advisory panel urged the government on Thursday to reject Merck & Co Inc's latest bid to sell the first cholesterol-lowering drug without a prescription.
294702
The reputation of the drug industry took another heavy blow yesterday with a report suggesting that Merck had fought for years to cover up evidence linking its painkiller Vioxx to heart attacks and strokes.
65762
The stunning announcement is likely to damage the companyÂs prospects for decades as research linked the drug to deaths and heart problems.
316374
Merck &amp; Co&#39;s decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company.
575614
Merck and Schering report bad news, but how much will it affect sales?
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
569961
By Rosie Murray-West, City Correspondent (Filed: 01/10/2004). US pharmaceutical giant Merck lost about a quarter of its value yesterday after it pulled arthritis drug Vioxx owing to concerns over heart attacks as a side-effect.
195152
Merck &amp; Co. yesterday pulled the blockbuster pain medicine Vioxx off the market, announcing that a new company-sponsored study showed the drug doubled the risk
328935
SOME of the biggest companies in the drug industry are shivering under an avalanche of bad news. Merck has already been hit hard by the withdrawal of Vioxx, its arthritis drug.
465044
NEW YORK (Dow Jones/AP) -- A high-dose regimen of Merck &amp; Co.&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of zocor in preventing a recurrence of cardiac events in patients who&#39;d already had heart
142813
A major new study out Monday found that a cholesterol-lowering drug pulled from the US market in 2001 had a substantially higher risk of a serious side effect than three top-selling competitors.